Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
Journal of Clinical Pathology
|
June 19, 2013
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
E Frei, C Visco, Z Y Xu-Monette, et al.
The American Journal of Surgical Pathology
|
February 27, 2001
Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival
A Fernández-Vázquez, J L Rodríguez-Peralto, M A Martínez, et al.
Leukemia
|
July 6, 2007
Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation
A Rodríguez, R Villuendas, L Yáñez, et al.
Leukemia
|
December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
E Matutes, D Oscier, C Montalban, et al.
Leukemia
|
May 21, 2010
Mantle cell lymphoma: transcriptional regulation by microRNAs
L Di Lisio, G Gómez-López, M Sánchez-Beato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 30, 2020
Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features
W Kempf, C Mitteldorf, M Battistella, et al.
Leukemia
|
July 29, 2015
Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development
A M Roncero, P López-Nieva, M A Cobos-Fernández, et al.
Leukemia
|
September 28, 2013
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
J Menezes, F Acquadro, M Wiseman, et al.
Blood Cancer Journal
|
April 20, 2013
Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas
S M Rodríguez-Pinilla, M E C Sánchez, J Rodríguez, et al.
Leukemia
|
January 7, 2012
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications
V Bikos, N Darzentas, A Hadzidimitriou, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
Journal of Clinical Pathology
|
June 19, 2013
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
E Frei, C Visco, Z Y Xu-Monette, et al.
The American Journal of Surgical Pathology
|
February 27, 2001
Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival
A Fernández-Vázquez, J L Rodríguez-Peralto, M A Martínez, et al.
Leukemia
|
July 6, 2007
Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation
A Rodríguez, R Villuendas, L Yáñez, et al.
Leukemia
|
December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
E Matutes, D Oscier, C Montalban, et al.
Leukemia
|
May 21, 2010
Mantle cell lymphoma: transcriptional regulation by microRNAs
L Di Lisio, G Gómez-López, M Sánchez-Beato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 30, 2020
Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features
W Kempf, C Mitteldorf, M Battistella, et al.
Leukemia
|
July 29, 2015
Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development
A M Roncero, P López-Nieva, M A Cobos-Fernández, et al.
Leukemia
|
September 28, 2013
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
J Menezes, F Acquadro, M Wiseman, et al.
Blood Cancer Journal
|
April 20, 2013
Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas
S M Rodríguez-Pinilla, M E C Sánchez, J Rodríguez, et al.
Leukemia
|
January 7, 2012
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications
V Bikos, N Darzentas, A Hadzidimitriou, et al.
Page
of 12